

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.24277894 |
| 2 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.08424499 |
| 3 | proteasome assembly (GO:0043248) | 5.00826584 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 4.65941952 |
| 5 | viral transcription (GO:0019083) | 4.51355651 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.48894146 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 4.44120706 |
| 8 | translational termination (GO:0006415) | 4.43245743 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.34307445 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.30910140 |
| 11 | cullin deneddylation (GO:0010388) | 4.29566350 |
| 12 | spliceosomal snRNP assembly (GO:0000387) | 4.20741896 |
| 13 | ribosomal large subunit biogenesis (GO:0042273) | 4.19418825 |
| 14 | protein deneddylation (GO:0000338) | 4.17853486 |
| 15 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.16170008 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.10846261 |
| 17 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.09280728 |
| 18 | translational initiation (GO:0006413) | 4.08188436 |
| 19 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.05624558 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.03089011 |
| 21 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.02343254 |
| 22 | termination of RNA polymerase III transcription (GO:0006386) | 4.02343254 |
| 23 | translational elongation (GO:0006414) | 4.01989134 |
| 24 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.01273485 |
| 25 | purine nucleobase biosynthetic process (GO:0009113) | 3.98207582 |
| 26 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.97775589 |
| 27 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.96678972 |
| 28 | negative regulation of ligase activity (GO:0051352) | 3.96678972 |
| 29 | cotranslational protein targeting to membrane (GO:0006613) | 3.93842017 |
| 30 | protein targeting to ER (GO:0045047) | 3.88410132 |
| 31 | nucleobase biosynthetic process (GO:0046112) | 3.88109113 |
| 32 | ribosome biogenesis (GO:0042254) | 3.82784356 |
| 33 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.82597668 |
| 34 | protein retention in ER lumen (GO:0006621) | 3.80042054 |
| 35 | GDP-mannose metabolic process (GO:0019673) | 3.79154003 |
| 36 | translation (GO:0006412) | 3.79105862 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.78768340 |
| 38 | protein localization to endoplasmic reticulum (GO:0070972) | 3.75000891 |
| 39 | regulation of mitochondrial translation (GO:0070129) | 3.74898146 |
| 40 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.70544908 |
| 41 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.70456684 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 3.70456684 |
| 43 | DNA replication checkpoint (GO:0000076) | 3.69259662 |
| 44 | viral mRNA export from host cell nucleus (GO:0046784) | 3.68376083 |
| 45 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.66268715 |
| 46 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.66118878 |
| 47 | cellular protein complex disassembly (GO:0043624) | 3.65860610 |
| 48 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.65353543 |
| 49 | DNA strand elongation (GO:0022616) | 3.62972516 |
| 50 | spliceosomal complex assembly (GO:0000245) | 3.62204666 |
| 51 | * rRNA processing (GO:0006364) | 3.60037291 |
| 52 | protein insertion into membrane (GO:0051205) | 3.59861108 |
| 53 | protein targeting to membrane (GO:0006612) | 3.57752109 |
| 54 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.57547223 |
| 55 | protein maturation by protein folding (GO:0022417) | 3.55613633 |
| 56 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.54464748 |
| 57 | 7-methylguanosine mRNA capping (GO:0006370) | 3.54250780 |
| 58 | iron-sulfur cluster assembly (GO:0016226) | 3.53802615 |
| 59 | metallo-sulfur cluster assembly (GO:0031163) | 3.53802615 |
| 60 | viral life cycle (GO:0019058) | 3.53239521 |
| 61 | establishment of protein localization to mitochondrion (GO:0072655) | 3.52549361 |
| 62 | UV protection (GO:0009650) | 3.52054063 |
| 63 | positive regulation of ligase activity (GO:0051351) | 3.52010982 |
| 64 | DNA replication initiation (GO:0006270) | 3.51608575 |
| 65 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.49602473 |
| 66 | ribosome assembly (GO:0042255) | 3.48698258 |
| 67 | cellular component biogenesis (GO:0044085) | 3.47469550 |
| 68 | rRNA modification (GO:0000154) | 3.47057955 |
| 69 | * rRNA metabolic process (GO:0016072) | 3.45975853 |
| 70 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.45472431 |
| 71 | RNA capping (GO:0036260) | 3.44235169 |
| 72 | 7-methylguanosine RNA capping (GO:0009452) | 3.44235169 |
| 73 | negative regulation of cell size (GO:0045792) | 3.43903384 |
| 74 | protein targeting to mitochondrion (GO:0006626) | 3.43354499 |
| 75 | mitotic metaphase plate congression (GO:0007080) | 3.42303222 |
| 76 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.40864802 |
| 77 | apoptotic process involved in morphogenesis (GO:0060561) | 3.39894056 |
| 78 | pentose metabolic process (GO:0019321) | 3.36948191 |
| 79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.34815882 |
| 80 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.34815882 |
| 81 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.34815882 |
| 82 | mitochondrion transport along microtubule (GO:0047497) | 3.34694937 |
| 83 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.34694937 |
| 84 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.34648423 |
| 85 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.34028035 |
| 86 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.34028035 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.34003734 |
| 88 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.34003734 |
| 89 | chaperone-mediated protein transport (GO:0072321) | 3.33142602 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 3.31474444 |
| 91 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.31139689 |
| 92 | termination of RNA polymerase I transcription (GO:0006363) | 3.29805770 |
| 93 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.29621558 |
| 94 | protein complex disassembly (GO:0043241) | 3.29304593 |
| 95 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.28338959 |
| 96 | histone arginine methylation (GO:0034969) | 3.27296974 |
| 97 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.26005239 |
| 98 | tooth mineralization (GO:0034505) | 3.23601387 |
| 99 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.23142751 |
| 100 | GTP biosynthetic process (GO:0006183) | 3.22960087 |
| 101 | UTP biosynthetic process (GO:0006228) | 3.22485291 |
| 102 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.21867099 |
| 103 | UTP metabolic process (GO:0046051) | 3.21402252 |
| 104 | pseudouridine synthesis (GO:0001522) | 3.21030110 |
| 105 | macromolecular complex disassembly (GO:0032984) | 3.18437425 |
| 106 | regulation of ligase activity (GO:0051340) | 3.15815552 |
| 107 | protein localization to mitochondrion (GO:0070585) | 3.14505670 |
| 108 | response to misfolded protein (GO:0051788) | 3.13093795 |
| 109 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.12893786 |
| 110 | transcription from RNA polymerase I promoter (GO:0006360) | 3.09848871 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.08418718 |
| 112 | regulation of early endosome to late endosome transport (GO:2000641) | 3.07645492 |
| 113 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.06927281 |
| 114 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.04537582 |
| 115 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.03126200 |
| 116 | telomere maintenance via recombination (GO:0000722) | 3.02187537 |
| 117 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.02149262 |
| 118 | establishment of integrated proviral latency (GO:0075713) | 3.00304435 |
| 119 | cell cycle G1/S phase transition (GO:0044843) | 2.99651443 |
| 120 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.99651443 |
| 121 | ncRNA 3-end processing (GO:0043628) | 2.97300273 |
| 122 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97030772 |
| 123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96981490 |
| 124 | negative regulation of chromosome segregation (GO:0051985) | 2.96890869 |
| 125 | DNA-templated transcription, termination (GO:0006353) | 2.96521058 |
| 126 | lens fiber cell development (GO:0070307) | 2.96244551 |
| 127 | de novo protein folding (GO:0006458) | 2.95941688 |
| 128 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.93323639 |
| 129 | protein localization to endosome (GO:0036010) | 2.91445188 |
| 130 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.91083213 |
| 131 | proline biosynthetic process (GO:0006561) | 2.90534056 |
| 132 | establishment of protein localization to membrane (GO:0090150) | 2.87431654 |
| 133 | respiratory electron transport chain (GO:0022904) | 2.84665043 |
| 134 | CTP metabolic process (GO:0046036) | 2.82470219 |
| 135 | CTP biosynthetic process (GO:0006241) | 2.82470219 |
| 136 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.81776820 |
| 137 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.80142938 |
| 138 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.77890575 |
| 139 | mitochondrial calcium ion transport (GO:0006851) | 2.77740136 |
| 140 | electron transport chain (GO:0022900) | 2.77646765 |
| 141 | mitotic nuclear envelope reassembly (GO:0007084) | 2.73356695 |
| 142 | nuclear envelope reassembly (GO:0031468) | 2.73356695 |
| 143 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.70235919 |
| 144 | activation of MAPKKK activity (GO:0000185) | 2.69651939 |
| 145 | deoxyribonucleotide catabolic process (GO:0009264) | 2.69253714 |
| 146 | mitochondrial fusion (GO:0008053) | 2.69012088 |
| 147 | viral protein processing (GO:0019082) | 2.68681595 |
| 148 | pentose-phosphate shunt (GO:0006098) | 2.67109075 |
| 149 | positive regulation of mitochondrion organization (GO:0010822) | 2.66169945 |
| 150 | barbed-end actin filament capping (GO:0051016) | 2.65552620 |
| 151 | regulation of protein heterodimerization activity (GO:0043497) | 2.65078435 |
| 152 | prostanoid biosynthetic process (GO:0046457) | 2.62822971 |
| 153 | prostaglandin biosynthetic process (GO:0001516) | 2.62822971 |
| 154 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.62476727 |
| 155 | T cell apoptotic process (GO:0070231) | 2.62473985 |
| 156 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.61937378 |
| 157 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.59393825 |
| 158 | regulation of chromatin binding (GO:0035561) | 2.57033457 |
| 159 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.56827847 |
| 160 | post-embryonic morphogenesis (GO:0009886) | 2.55873112 |
| 161 | cell migration in hindbrain (GO:0021535) | 2.54536423 |
| 162 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.53443198 |
| 163 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.53180502 |
| 164 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.52557378 |
| 165 | modulation by virus of host process (GO:0019054) | 2.52189472 |
| 166 | protein targeting (GO:0006605) | 2.51276897 |
| 167 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.50443290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.52295455 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.46666994 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.13926218 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.07639754 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.91833934 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.88256060 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.70299220 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.64948677 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.39266152 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.25252518 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.17155729 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.15263655 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.15142655 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.99441801 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89603498 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.86646315 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.82452170 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.72616082 |
| 19 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.57215625 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.55618151 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.54448154 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.52720120 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.51543235 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.50400795 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.41916578 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.40391759 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.36243868 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.34228287 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.33529320 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.30765413 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28903387 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.27644053 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20095414 |
| 34 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.19707666 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18873143 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.16503204 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12338598 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11278121 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.09826935 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.01280591 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00877075 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00252571 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92033412 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.90484955 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.89901500 |
| 46 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.88690001 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.86972639 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84789412 |
| 49 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83870683 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.83089930 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.80201762 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78074937 |
| 53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72174353 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.71516582 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69561900 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.69014587 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68787656 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67660004 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67491435 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67260094 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64518404 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62673347 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.62068839 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.57561062 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.57060590 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55207218 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.54269012 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53741807 |
| 69 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.52896625 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52592643 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51760603 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51432822 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48640458 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47964141 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47602795 |
| 76 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46947498 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45474789 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44982197 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43627286 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43609126 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41434249 |
| 82 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38677089 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38536739 |
| 84 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.38225840 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37526664 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.37386881 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36623211 |
| 88 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35914636 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35837953 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35253265 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34136733 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33225492 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.32601740 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32228510 |
| 95 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31681756 |
| 96 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30717615 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.29242545 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27162143 |
| 99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27052834 |
| 100 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22208559 |
| 101 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21993634 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21803539 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21715949 |
| 104 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20475222 |
| 105 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.20247077 |
| 106 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.19474660 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18269513 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18095327 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 1.17133937 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16549928 |
| 111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16187699 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13987153 |
| 113 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13717403 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.13524060 |
| 115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12919201 |
| 116 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.12167159 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11902404 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11418869 |
| 119 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.10949102 |
| 120 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10393108 |
| 121 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10162598 |
| 122 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.09158290 |
| 123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07835496 |
| 124 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07815200 |
| 125 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07107884 |
| 126 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06839002 |
| 127 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.06441121 |
| 128 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05965866 |
| 129 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05398291 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05168416 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04859149 |
| 132 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04806403 |
| 133 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04517807 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04512115 |
| 135 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03532641 |
| 136 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03498104 |
| 137 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.03439339 |
| 138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02266584 |
| 139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02253657 |
| 140 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02238557 |
| 141 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02223731 |
| 142 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01470687 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00780804 |
| 144 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99978498 |
| 145 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99531701 |
| 146 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99253561 |
| 147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98809662 |
| 148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98778365 |
| 149 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98428589 |
| 150 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98092862 |
| 151 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.97417599 |
| 152 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97210747 |
| 153 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96714741 |
| 154 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95973872 |
| 155 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94009995 |
| 156 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92766402 |
| 157 | MYC_22102868_ChIP-Seq_BL_Human | 0.90510728 |
| 158 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.90410565 |
| 159 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89922636 |
| 160 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88666712 |
| 161 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88223040 |
| 162 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88033197 |
| 163 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.87896416 |
| 164 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87603923 |
| 165 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.87565369 |
| 166 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85752292 |
| 167 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83860192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.08829708 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.77007444 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.15024491 |
| 4 | MP0003077_abnormal_cell_cycle | 3.71935428 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.55445818 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.48178887 |
| 7 | MP0005451_abnormal_body_composition | 3.36147034 |
| 8 | MP0009278_abnormal_bone_marrow | 3.27222464 |
| 9 | MP0008932_abnormal_embryonic_tissue | 3.11210142 |
| 10 | MP0003123_paternal_imprinting | 3.00437606 |
| 11 | MP0009840_abnormal_foam_cell | 2.96418492 |
| 12 | MP0008058_abnormal_DNA_repair | 2.91462742 |
| 13 | MP0004858_abnormal_nervous_system | 2.82974614 |
| 14 | MP0003718_maternal_effect | 2.78586648 |
| 15 | MP0008057_abnormal_DNA_replication | 2.75302823 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.53331426 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.41551966 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.38480885 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 2.36251204 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.35589538 |
| 21 | MP0005623_abnormal_meninges_morphology | 2.34326049 |
| 22 | MP0003786_premature_aging | 2.32619096 |
| 23 | MP0000003_abnormal_adipose_tissue | 2.32411060 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.29383489 |
| 25 | MP0003329_amyloid_beta_deposits | 2.20643051 |
| 26 | MP0001730_embryonic_growth_arrest | 2.12062461 |
| 27 | MP0004133_heterotaxia | 2.11078012 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 2.10480786 |
| 29 | MP0001529_abnormal_vocalization | 2.06906276 |
| 30 | MP0010030_abnormal_orbit_morphology | 2.04174317 |
| 31 | MP0001348_abnormal_lacrimal_gland | 2.03798202 |
| 32 | MP0000678_abnormal_parathyroid_gland | 2.02206108 |
| 33 | MP0005375_adipose_tissue_phenotype | 1.99679052 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.99432570 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.88338622 |
| 36 | MP0004859_abnormal_synaptic_plasticity | 1.84033980 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.83740870 |
| 38 | MP0003122_maternal_imprinting | 1.82570586 |
| 39 | MP0003121_genomic_imprinting | 1.80338936 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.79788315 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.79493682 |
| 42 | MP0000350_abnormal_cell_proliferation | 1.77504937 |
| 43 | MP0000358_abnormal_cell_content/ | 1.75603532 |
| 44 | MP0001849_ear_inflammation | 1.71810242 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.71421936 |
| 46 | MP0004510_myositis | 1.69441040 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.68765158 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.68564337 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.66489801 |
| 50 | MP0005501_abnormal_skin_physiology | 1.65902845 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.60659909 |
| 52 | MP0003315_abnormal_perineum_morphology | 1.58762884 |
| 53 | MP0002751_abnormal_autonomic_nervous | 1.56758259 |
| 54 | MP0001697_abnormal_embryo_size | 1.55966885 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.54702882 |
| 56 | MP0002080_prenatal_lethality | 1.53198646 |
| 57 | MP0003119_abnormal_digestive_system | 1.50141984 |
| 58 | MP0001905_abnormal_dopamine_level | 1.47324488 |
| 59 | MP0000759_abnormal_skeletal_muscle | 1.46830425 |
| 60 | MP0000681_abnormal_thyroid_gland | 1.45672553 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.40766748 |
| 62 | MP0002085_abnormal_embryonic_tissue | 1.39716349 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.36701625 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.34877935 |
| 65 | MP0003279_aneurysm | 1.32490966 |
| 66 | MP0009384_cardiac_valve_regurgitation | 1.32389838 |
| 67 | MP0001672_abnormal_embryogenesis/_devel | 1.31125558 |
| 68 | MP0005380_embryogenesis_phenotype | 1.31125558 |
| 69 | MP0000313_abnormal_cell_death | 1.30548682 |
| 70 | MP0002796_impaired_skin_barrier | 1.24943132 |
| 71 | MP0001542_abnormal_bone_strength | 1.22900183 |
| 72 | MP0002822_catalepsy | 1.22827619 |
| 73 | MP0005670_abnormal_white_adipose | 1.22456778 |
| 74 | MP0000747_muscle_weakness | 1.19439386 |
| 75 | MP0000733_abnormal_muscle_development | 1.19232949 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.16958470 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.16574033 |
| 78 | MP0002084_abnormal_developmental_patter | 1.15556262 |
| 79 | MP0000751_myopathy | 1.14881725 |
| 80 | MP0000343_altered_response_to | 1.14860230 |
| 81 | MP0000566_synostosis | 1.14065671 |
| 82 | MP0002160_abnormal_reproductive_system | 1.13368778 |
| 83 | MP0005503_abnormal_tendon_morphology | 1.11783794 |
| 84 | MP0003303_peritoneal_inflammation | 1.11296848 |
| 85 | MP0001727_abnormal_embryo_implantation | 1.09940535 |
| 86 | MP0003984_embryonic_growth_retardation | 1.09855185 |
| 87 | MP0002163_abnormal_gland_morphology | 1.09689736 |
| 88 | MP0002088_abnormal_embryonic_growth/wei | 1.07761282 |
| 89 | MP0004233_abnormal_muscle_weight | 1.04713357 |
| 90 | MP0005394_taste/olfaction_phenotype | 1.03858813 |
| 91 | MP0005499_abnormal_olfactory_system | 1.03858813 |
| 92 | MP0005508_abnormal_skeleton_morphology | 1.03818891 |
| 93 | MP0004130_abnormal_muscle_cell | 1.02998217 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 1.02233940 |
| 95 | MP0001545_abnormal_hematopoietic_system | 1.02233940 |
| 96 | MP0001145_abnormal_male_reproductive | 1.01855267 |
| 97 | MP0002210_abnormal_sex_determination | 0.99461793 |
| 98 | MP0008260_abnormal_autophagy | 0.99416376 |
| 99 | MP0005266_abnormal_metabolism | 0.99313104 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.98898962 |
| 101 | MP0004142_abnormal_muscle_tone | 0.98224723 |
| 102 | MP0003879_abnormal_hair_cell | 0.97584546 |
| 103 | MP0004087_abnormal_muscle_fiber | 0.95874735 |
| 104 | MP0005389_reproductive_system_phenotype | 0.94644684 |
| 105 | MP0000858_altered_metastatic_potential | 0.93248129 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.91803337 |
| 107 | MP0002971_abnormal_brown_adipose | 0.91256973 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.91218618 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.90855218 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.90803570 |
| 111 | MP0002019_abnormal_tumor_incidence | 0.90670588 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.89196005 |
| 113 | MP0000762_abnormal_tongue_morphology | 0.89154174 |
| 114 | MP0003634_abnormal_glial_cell | 0.86457324 |
| 115 | MP0000490_abnormal_crypts_of | 0.86291938 |
| 116 | MP0002938_white_spotting | 0.85243362 |
| 117 | MP0001919_abnormal_reproductive_system | 0.84869653 |
| 118 | MP0000604_amyloidosis | 0.83085734 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.82104553 |
| 120 | MP0005384_cellular_phenotype | 0.81751655 |
| 121 | MP0002736_abnormal_nociception_after | 0.79911099 |
| 122 | MP0000749_muscle_degeneration | 0.79308176 |
| 123 | MP0002269_muscular_atrophy | 0.79059727 |
| 124 | MP0000049_abnormal_middle_ear | 0.78660797 |
| 125 | MP0001293_anophthalmia | 0.77657286 |
| 126 | MP0000653_abnormal_sex_gland | 0.76925674 |
| 127 | MP0000750_abnormal_muscle_regeneration | 0.76903137 |
| 128 | MP0005330_cardiomyopathy | 0.76720972 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.76228122 |
| 130 | MP0002111_abnormal_tail_morphology | 0.75601710 |
| 131 | MP0004145_abnormal_muscle_electrophysio | 0.75545924 |
| 132 | MP0001663_abnormal_digestive_system | 0.75364815 |
| 133 | MP0003861_abnormal_nervous_system | 0.74799734 |
| 134 | MP0008874_decreased_physiological_sensi | 0.74727098 |
| 135 | MP0005076_abnormal_cell_differentiation | 0.74720663 |
| 136 | MP0009672_abnormal_birth_weight | 0.73516205 |
| 137 | MP0003436_decreased_susceptibility_to | 0.73289975 |
| 138 | MP0001929_abnormal_gametogenesis | 0.73275426 |
| 139 | MP0000703_abnormal_thymus_morphology | 0.72193719 |
| 140 | MP0005390_skeleton_phenotype | 0.72047867 |
| 141 | MP0002086_abnormal_extraembryonic_tissu | 0.72029186 |
| 142 | MP0001873_stomach_inflammation | 0.71390310 |
| 143 | MP0002102_abnormal_ear_morphology | 0.69652610 |
| 144 | MP0005193_abnormal_anterior_eye | 0.69175467 |
| 145 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69037930 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.67153431 |
| 147 | MP0003567_abnormal_fetal_cardiomyocyte | 0.67122241 |
| 148 | MP0000955_abnormal_spinal_cord | 0.65253375 |
| 149 | MP0003283_abnormal_digestive_organ | 0.64696182 |
| 150 | MP0004197_abnormal_fetal_growth/weight/ | 0.64611406 |
| 151 | MP0002184_abnormal_innervation | 0.64140813 |
| 152 | MP0004272_abnormal_basement_membrane | 0.63784422 |
| 153 | MP0002114_abnormal_axial_skeleton | 0.63150313 |
| 154 | MP0002234_abnormal_pharynx_morphology | 0.62399576 |
| 155 | MP0001188_hyperpigmentation | 0.62156888 |
| 156 | MP0003186_abnormal_redox_activity | 0.62132427 |
| 157 | MP0003385_abnormal_body_wall | 0.61033287 |
| 158 | MP0009250_abnormal_appendicular_skeleto | 0.60506887 |
| 159 | MP0002733_abnormal_thermal_nociception | 0.60306872 |
| 160 | MP0005395_other_phenotype | 0.60236860 |
| 161 | MP0002970_abnormal_white_adipose | 0.59561220 |
| 162 | MP0008789_abnormal_olfactory_epithelium | 0.58607581 |
| 163 | MP0001764_abnormal_homeostasis | 0.57259004 |
| 164 | MP0000015_abnormal_ear_pigmentation | 0.56860643 |
| 165 | MP0002169_no_abnormal_phenotype | 0.55887386 |
| 166 | MP0003942_abnormal_urinary_system | 0.55719804 |
| 167 | MP0002873_normal_phenotype | 0.54539996 |
| 168 | MP0009053_abnormal_anal_canal | 0.53437537 |
| 169 | MP0005379_endocrine/exocrine_gland_phen | 0.53172011 |
| 170 | MP0008995_early_reproductive_senescence | 0.52992650 |
| 171 | MP0005621_abnormal_cell_physiology | 0.51489358 |
| 172 | MP0002127_abnormal_cardiovascular_syste | 0.50948287 |
| 173 | MP0005376_homeostasis/metabolism_phenot | 0.50656794 |
| 174 | MP0002932_abnormal_joint_morphology | 0.50126813 |
| 175 | MP0008770_decreased_survivor_rate | 0.49888084 |
| 176 | MP0002161_abnormal_fertility/fecundity | 0.49319984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.39839601 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.26187138 |
| 3 | Achilles tendon contracture (HP:0001771) | 4.06691812 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 4.03936505 |
| 5 | Cerebral hypomyelination (HP:0006808) | 3.82569062 |
| 6 | Breast hypoplasia (HP:0003187) | 3.73967662 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.72666935 |
| 8 | Reticulocytopenia (HP:0001896) | 3.69028803 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.63686036 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.61822171 |
| 11 | Abnormality of the Achilles tendon (HP:0005109) | 3.48280238 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.48247621 |
| 13 | Patellar aplasia (HP:0006443) | 3.45110975 |
| 14 | Rough bone trabeculation (HP:0100670) | 3.43236614 |
| 15 | Increased CSF lactate (HP:0002490) | 3.33574037 |
| 16 | Oral leukoplakia (HP:0002745) | 3.32934345 |
| 17 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.31372149 |
| 18 | Hyperacusis (HP:0010780) | 3.30390968 |
| 19 | Microretrognathia (HP:0000308) | 3.27018939 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.25728505 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.25358080 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.25358080 |
| 23 | Carpal bone hypoplasia (HP:0001498) | 3.25335213 |
| 24 | Macrocytic anemia (HP:0001972) | 3.24949034 |
| 25 | Increased serum lactate (HP:0002151) | 3.16361395 |
| 26 | Secondary amenorrhea (HP:0000869) | 3.09006094 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.07182745 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 3.06530359 |
| 29 | Degeneration of anterior horn cells (HP:0002398) | 3.05330662 |
| 30 | Abnormality of the anterior horn cell (HP:0006802) | 3.05330662 |
| 31 | Hyperthyroidism (HP:0000836) | 3.02576691 |
| 32 | Protrusio acetabuli (HP:0003179) | 2.99787909 |
| 33 | Emotional lability (HP:0000712) | 2.99221028 |
| 34 | Myopathic facies (HP:0002058) | 2.98279532 |
| 35 | Acute encephalopathy (HP:0006846) | 2.94140060 |
| 36 | Abnormality of glycolysis (HP:0004366) | 2.93517666 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.93517666 |
| 38 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.93200567 |
| 39 | Hepatic necrosis (HP:0002605) | 2.90470793 |
| 40 | Broad distal phalanx of finger (HP:0009836) | 2.90053060 |
| 41 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.89712989 |
| 42 | Vertebral compression fractures (HP:0002953) | 2.88484881 |
| 43 | Aplastic anemia (HP:0001915) | 2.83481912 |
| 44 | Increased hepatocellular lipid droplets (HP:0006565) | 2.77650767 |
| 45 | Insomnia (HP:0100785) | 2.75033526 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.73074733 |
| 47 | Type 1 muscle fiber predominance (HP:0003803) | 2.67186824 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.65993075 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.64210074 |
| 50 | Premature rupture of membranes (HP:0001788) | 2.64157862 |
| 51 | Abnormality of the labia minora (HP:0012880) | 2.63606044 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.63081397 |
| 53 | Premature graying of hair (HP:0002216) | 2.60152837 |
| 54 | Pallor (HP:0000980) | 2.59505595 |
| 55 | Unsteady gait (HP:0002317) | 2.59229313 |
| 56 | Delusions (HP:0000746) | 2.58566199 |
| 57 | CNS demyelination (HP:0007305) | 2.57485154 |
| 58 | CNS hypomyelination (HP:0003429) | 2.54935836 |
| 59 | Microvesicular hepatic steatosis (HP:0001414) | 2.54217359 |
| 60 | Lactic acidosis (HP:0003128) | 2.52552741 |
| 61 | Selective tooth agenesis (HP:0001592) | 2.52444315 |
| 62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.40039782 |
| 63 | Shoulder girdle muscle weakness (HP:0003547) | 2.39298393 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.38474520 |
| 65 | Premature ovarian failure (HP:0008209) | 2.37884460 |
| 66 | Increased connective tissue (HP:0009025) | 2.37504251 |
| 67 | Progressive external ophthalmoplegia (HP:0000590) | 2.37005708 |
| 68 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.34645040 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.32200227 |
| 70 | Poor suck (HP:0002033) | 2.32037647 |
| 71 | Hyperparathyroidism (HP:0000843) | 2.31491712 |
| 72 | Overriding aorta (HP:0002623) | 2.31333885 |
| 73 | Multiple enchondromatosis (HP:0005701) | 2.31185723 |
| 74 | Hypertensive crisis (HP:0100735) | 2.30481226 |
| 75 | Exercise intolerance (HP:0003546) | 2.30458892 |
| 76 | Abnormal trabecular bone morphology (HP:0100671) | 2.29682875 |
| 77 | Cellular immunodeficiency (HP:0005374) | 2.29624871 |
| 78 | Abnormality of dentin (HP:0010299) | 2.29463650 |
| 79 | Myokymia (HP:0002411) | 2.29452110 |
| 80 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.28447966 |
| 81 | Upper limb amyotrophy (HP:0009129) | 2.28111769 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.28111769 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26242195 |
| 84 | Hypoplasia of the pons (HP:0012110) | 2.25892079 |
| 85 | Truncus arteriosus (HP:0001660) | 2.25743800 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 2.25546764 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.24182606 |
| 88 | Trismus (HP:0000211) | 2.23693354 |
| 89 | Cleft eyelid (HP:0000625) | 2.23454768 |
| 90 | Exertional dyspnea (HP:0002875) | 2.22957574 |
| 91 | Colon cancer (HP:0003003) | 2.20821123 |
| 92 | Bulbar palsy (HP:0001283) | 2.19317911 |
| 93 | Spinal rigidity (HP:0003306) | 2.18207959 |
| 94 | Ankle clonus (HP:0011448) | 2.17351161 |
| 95 | Absent thumb (HP:0009777) | 2.16134146 |
| 96 | Turricephaly (HP:0000262) | 2.15682982 |
| 97 | Hypercalcemia (HP:0003072) | 2.13971217 |
| 98 | Respiratory failure (HP:0002878) | 2.10667167 |
| 99 | Absent radius (HP:0003974) | 2.09892281 |
| 100 | Genu recurvatum (HP:0002816) | 2.09835420 |
| 101 | Horseshoe kidney (HP:0000085) | 2.09302596 |
| 102 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09028907 |
| 103 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09028907 |
| 104 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09028907 |
| 105 | Elbow flexion contracture (HP:0002987) | 2.08791045 |
| 106 | Rhabdomyolysis (HP:0003201) | 2.08277622 |
| 107 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07157400 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 2.07157400 |
| 109 | Hyperalaninemia (HP:0003348) | 2.07157400 |
| 110 | Short nail (HP:0001799) | 2.03973665 |
| 111 | Aplasia involving forearm bones (HP:0009822) | 2.03553919 |
| 112 | Absent forearm bone (HP:0003953) | 2.03553919 |
| 113 | Axonal loss (HP:0003447) | 2.03275600 |
| 114 | Fragile skin (HP:0001030) | 2.02298323 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 2.02211151 |
| 116 | Facial cleft (HP:0002006) | 2.01475667 |
| 117 | Mitral regurgitation (HP:0001653) | 2.01374653 |
| 118 | Elfin facies (HP:0004428) | 2.01269360 |
| 119 | 11 pairs of ribs (HP:0000878) | 2.00978755 |
| 120 | Postnatal microcephaly (HP:0005484) | 2.00784560 |
| 121 | Exercise-induced myalgia (HP:0003738) | 2.00489674 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 2.00318264 |
| 123 | Long palpebral fissure (HP:0000637) | 1.99370961 |
| 124 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.99319522 |
| 125 | Athetosis (HP:0002305) | 1.98310246 |
| 126 | Neoplasm of the pancreas (HP:0002894) | 1.96866224 |
| 127 | Round ear (HP:0100830) | 1.96535172 |
| 128 | Abnormality of reticulocytes (HP:0004312) | 1.95601972 |
| 129 | Ulnar bowing (HP:0003031) | 1.95410158 |
| 130 | Patellar dislocation (HP:0002999) | 1.94943751 |
| 131 | Cerebral edema (HP:0002181) | 1.94934134 |
| 132 | Growth hormone excess (HP:0000845) | 1.93854515 |
| 133 | Calcaneovalgus deformity (HP:0001848) | 1.93238032 |
| 134 | Atelectasis (HP:0100750) | 1.92637408 |
| 135 | Adducted thumb (HP:0001181) | 1.92564913 |
| 136 | Dysautonomia (HP:0002459) | 1.92425648 |
| 137 | Abnormal number of incisors (HP:0011064) | 1.91093104 |
| 138 | Stridor (HP:0010307) | 1.90728618 |
| 139 | Bladder diverticulum (HP:0000015) | 1.89404724 |
| 140 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.89308716 |
| 141 | Absent epiphyses (HP:0010577) | 1.89308716 |
| 142 | Type I transferrin isoform profile (HP:0003642) | 1.88305834 |
| 143 | Cerebral inclusion bodies (HP:0100314) | 1.87443717 |
| 144 | Abnormality of the tricuspid valve (HP:0001702) | 1.86109867 |
| 145 | Renal Fanconi syndrome (HP:0001994) | 1.85636476 |
| 146 | Down-sloping shoulders (HP:0200021) | 1.85634524 |
| 147 | Self-mutilation (HP:0000742) | 1.84785622 |
| 148 | Renal duplication (HP:0000075) | 1.84313669 |
| 149 | Rectal prolapse (HP:0002035) | 1.83793655 |
| 150 | Congenital glaucoma (HP:0001087) | 1.83463735 |
| 151 | Muscle stiffness (HP:0003552) | 1.83448071 |
| 152 | Abnormality of the pons (HP:0007361) | 1.83144304 |
| 153 | Pelvic girdle muscle weakness (HP:0003749) | 1.82398025 |
| 154 | Irregular epiphyses (HP:0010582) | 1.82276718 |
| 155 | Hypokinesia (HP:0002375) | 1.81971926 |
| 156 | Supernumerary spleens (HP:0009799) | 1.81780911 |
| 157 | Female pseudohermaphroditism (HP:0010458) | 1.81169319 |
| 158 | Facial hemangioma (HP:0000329) | 1.80091584 |
| 159 | Muscle fiber inclusion bodies (HP:0100299) | 1.79033006 |
| 160 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78895443 |
| 161 | Hand muscle atrophy (HP:0009130) | 1.78786504 |
| 162 | Ragged-red muscle fibers (HP:0003200) | 1.78332308 |
| 163 | Failure to thrive in infancy (HP:0001531) | 1.76483696 |
| 164 | Sparse eyelashes (HP:0000653) | 1.75235525 |
| 165 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74770582 |
| 166 | Congenital malformation of the right heart (HP:0011723) | 1.73426955 |
| 167 | Double outlet right ventricle (HP:0001719) | 1.73426955 |
| 168 | Abnormality of the ileum (HP:0001549) | 1.72765457 |
| 169 | Joint stiffness (HP:0001387) | 1.72317403 |
| 170 | Nemaline bodies (HP:0003798) | 1.71741685 |
| 171 | Hypercortisolism (HP:0001578) | 1.71169416 |
| 172 | Personality changes (HP:0000751) | 1.71045155 |
| 173 | Severe visual impairment (HP:0001141) | 1.70806982 |
| 174 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.70361439 |
| 175 | Hydroureter (HP:0000072) | 1.70289787 |
| 176 | Difficulty climbing stairs (HP:0003551) | 1.68702456 |
| 177 | Premature skin wrinkling (HP:0100678) | 1.68418410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 6.31200018 |
| 2 | STK16 | 4.62649844 |
| 3 | WEE1 | 3.86685286 |
| 4 | TRIB3 | 3.69330955 |
| 5 | SRPK1 | 3.08787673 |
| 6 | SMG1 | 3.06339646 |
| 7 | EIF2AK1 | 2.84022361 |
| 8 | NME1 | 2.78836662 |
| 9 | IRAK3 | 2.74548396 |
| 10 | CDC7 | 2.72563082 |
| 11 | VRK2 | 2.60346862 |
| 12 | NME2 | 2.52392858 |
| 13 | TSSK6 | 2.44634832 |
| 14 | ERN1 | 2.42502397 |
| 15 | BRAF | 2.32833212 |
| 16 | SIK1 | 2.31798041 |
| 17 | TESK2 | 2.19501645 |
| 18 | PRPF4B | 2.07094347 |
| 19 | DYRK3 | 1.83822535 |
| 20 | TLK1 | 1.82440535 |
| 21 | PLK1 | 1.78368947 |
| 22 | PRKD3 | 1.75982518 |
| 23 | EPHB2 | 1.72240833 |
| 24 | BRSK2 | 1.71136053 |
| 25 | AURKA | 1.69030732 |
| 26 | NEK1 | 1.68797060 |
| 27 | TTN | 1.68663416 |
| 28 | ARAF | 1.68512989 |
| 29 | VRK1 | 1.63758501 |
| 30 | TTK | 1.60555622 |
| 31 | ICK | 1.60364953 |
| 32 | PLK4 | 1.57262661 |
| 33 | PNCK | 1.55020447 |
| 34 | MAP3K11 | 1.52741933 |
| 35 | NEK2 | 1.48354099 |
| 36 | PLK3 | 1.47708977 |
| 37 | SIK2 | 1.43953606 |
| 38 | EIF2AK3 | 1.42554489 |
| 39 | MAP3K12 | 1.41370990 |
| 40 | NTRK1 | 1.40873050 |
| 41 | MOS | 1.40786182 |
| 42 | CDK7 | 1.36950259 |
| 43 | CHEK2 | 1.36653441 |
| 44 | ACVR1B | 1.32607233 |
| 45 | PIM2 | 1.30167190 |
| 46 | BRSK1 | 1.24516595 |
| 47 | BCKDK | 1.23564495 |
| 48 | PASK | 1.22252776 |
| 49 | AURKB | 1.22230003 |
| 50 | DYRK2 | 1.20626842 |
| 51 | PRKD2 | 1.19035835 |
| 52 | EPHA2 | 1.15194956 |
| 53 | IRAK4 | 1.12838100 |
| 54 | MARK2 | 1.11574204 |
| 55 | KDR | 1.10638132 |
| 56 | RPS6KB2 | 1.08036450 |
| 57 | TYRO3 | 1.04831388 |
| 58 | LATS2 | 1.02678288 |
| 59 | TAOK1 | 1.02235191 |
| 60 | CCNB1 | 1.00395737 |
| 61 | ATR | 0.98924541 |
| 62 | DYRK1B | 0.94150518 |
| 63 | MAP4K1 | 0.92429173 |
| 64 | LIMK1 | 0.90425225 |
| 65 | DAPK1 | 0.89127099 |
| 66 | PKN2 | 0.88083916 |
| 67 | RPS6KA2 | 0.87416069 |
| 68 | DMPK | 0.87372892 |
| 69 | RPS6KC1 | 0.85538343 |
| 70 | RPS6KL1 | 0.85538343 |
| 71 | TESK1 | 0.85176722 |
| 72 | MAP2K3 | 0.84616145 |
| 73 | MAP3K1 | 0.84025718 |
| 74 | MAP3K8 | 0.82457933 |
| 75 | MAP3K10 | 0.82395358 |
| 76 | EEF2K | 0.82257066 |
| 77 | RPS6KA4 | 0.81441901 |
| 78 | MAP3K13 | 0.80732561 |
| 79 | PDPK1 | 0.79346401 |
| 80 | MAPKAPK3 | 0.77636245 |
| 81 | TBK1 | 0.77240847 |
| 82 | MARK1 | 0.76933393 |
| 83 | ZAK | 0.75193437 |
| 84 | CDK19 | 0.75151449 |
| 85 | CSNK2A2 | 0.74674694 |
| 86 | CDK8 | 0.74315443 |
| 87 | CSNK2A1 | 0.73811818 |
| 88 | PRKCI | 0.72997035 |
| 89 | SCYL2 | 0.72885997 |
| 90 | CHEK1 | 0.72762384 |
| 91 | IRAK2 | 0.69377283 |
| 92 | PAK1 | 0.68940725 |
| 93 | PAK6 | 0.67548371 |
| 94 | CSNK1G3 | 0.66925867 |
| 95 | ILK | 0.65718587 |
| 96 | PTK2 | 0.65283422 |
| 97 | RPS6KA6 | 0.64527436 |
| 98 | CAMKK1 | 0.64343729 |
| 99 | PHKG2 | 0.64267472 |
| 100 | PHKG1 | 0.64267472 |
| 101 | FLT3 | 0.62556385 |
| 102 | PAK4 | 0.61308851 |
| 103 | PRKG2 | 0.60397268 |
| 104 | MTOR | 0.58928192 |
| 105 | MINK1 | 0.58311150 |
| 106 | CDK2 | 0.56808219 |
| 107 | MKNK1 | 0.56041266 |
| 108 | HIPK2 | 0.55103566 |
| 109 | DAPK3 | 0.54639731 |
| 110 | MAPK11 | 0.54449953 |
| 111 | MAPK4 | 0.54283106 |
| 112 | GRK6 | 0.53398357 |
| 113 | GRK5 | 0.52451958 |
| 114 | TAOK2 | 0.52253955 |
| 115 | RIPK1 | 0.52142573 |
| 116 | CAMK2G | 0.51289509 |
| 117 | CDK14 | 0.51129725 |
| 118 | PTK6 | 0.51113537 |
| 119 | CSNK1E | 0.50731076 |
| 120 | CDK11A | 0.50647517 |
| 121 | MAPK12 | 0.49006725 |
| 122 | PDGFRA | 0.48770900 |
| 123 | CAMKK2 | 0.48743000 |
| 124 | RAF1 | 0.47956506 |
| 125 | CDK18 | 0.47421241 |
| 126 | UHMK1 | 0.46168022 |
| 127 | CDK15 | 0.45838135 |
| 128 | MKNK2 | 0.45813436 |
| 129 | MAP2K2 | 0.45462655 |
| 130 | RPS6KA5 | 0.45219519 |
| 131 | CDK1 | 0.45106164 |
| 132 | MAP2K4 | 0.43070567 |
| 133 | MAP3K9 | 0.42962306 |
| 134 | ABL2 | 0.41445172 |
| 135 | ATM | 0.41444581 |
| 136 | MUSK | 0.41191216 |
| 137 | STK38L | 0.39430845 |
| 138 | CDK4 | 0.39348364 |
| 139 | IRAK1 | 0.38562100 |
| 140 | CSNK1G1 | 0.37993090 |
| 141 | PAK2 | 0.37617627 |
| 142 | PDK2 | 0.36403323 |
| 143 | MAP3K4 | 0.35435095 |
| 144 | MAP2K7 | 0.35408071 |
| 145 | RPS6KA1 | 0.33977876 |
| 146 | ZAP70 | 0.33835565 |
| 147 | DDR2 | 0.32231064 |
| 148 | AKT2 | 0.31937496 |
| 149 | CAMK2B | 0.31789832 |
| 150 | CSNK1G2 | 0.28060114 |
| 151 | WNK3 | 0.27519329 |
| 152 | KSR1 | 0.25931712 |
| 153 | PRKCG | 0.24985641 |
| 154 | YES1 | 0.23666289 |
| 155 | MAPK9 | 0.22900469 |
| 156 | LRRK2 | 0.22071398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.70549970 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.66922481 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 4.02792439 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.81330312 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.42328396 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 3.41158208 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.21840959 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.87777085 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.83481533 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.78000419 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.55843511 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.52995208 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.51836774 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.41183112 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.38255669 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.38025341 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.20744188 |
| 18 | Protein export_Homo sapiens_hsa03060 | 2.06272945 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 2.05515508 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 2.00591133 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.91547764 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67141352 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.58792444 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.57435343 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.54359801 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.47911995 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46834880 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42158868 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38702532 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.34299634 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32855755 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32059536 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30759630 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.27808411 |
| 35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.27755742 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23718524 |
| 37 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.15600228 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11278288 |
| 39 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08436024 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07576043 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04352655 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04324871 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04054569 |
| 44 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.97790584 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96569746 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94674593 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94015317 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.93131913 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85054824 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83598230 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82255001 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80954672 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.79842939 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79426121 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79329592 |
| 56 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78512210 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77965339 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77199031 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76603505 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75574195 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74565726 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74414519 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74247055 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73091617 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70349080 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68682988 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68572269 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66422002 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66030656 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.65792957 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64223288 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63460824 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63161113 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61968844 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58838161 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58747163 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56924018 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55819659 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55749422 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54220994 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53788263 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53271593 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51668879 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50009422 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48805514 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47929474 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46539046 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45059648 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44961212 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.44521924 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42917135 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.42054876 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42042407 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39833084 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39542611 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39463149 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39246085 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39240609 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.39164405 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38839085 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.38830378 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37950889 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37927698 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36827557 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35458847 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.34294415 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34197272 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34191718 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33403898 |
| 110 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33274773 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33269572 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33146278 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32670822 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31466550 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29478834 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.29041024 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28561755 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28227596 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27549764 |
| 120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27474117 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.26196110 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25900363 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.25855007 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25793468 |
| 125 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23806688 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23598174 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23337973 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22827130 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22226990 |
| 130 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.16335223 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.16021671 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.14353997 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.12652878 |
| 134 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12058118 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.08440267 |
| 136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.07289806 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.06802527 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.04750854 |
| 139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.04112708 |
| 140 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.02816029 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.02213336 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.02152243 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01701580 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | -0.0622602 |
| 145 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0599937 |
| 146 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0584736 |
| 147 | Gap junction_Homo sapiens_hsa04540 | -0.0468320 |
| 148 | Wnt signaling pathway_Homo sapiens_hsa04310 | -0.0410640 |
| 149 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0363969 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0320351 |

